| RS1925418549 |
CDKL5
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS1925420814 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS1925421198 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS1925421858 |
CDKL5
|
Health Risk |
Pathogenic |
— |
| RS1925423909 |
CDKL5
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS192543787 |
HMX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1925449605 |
APOO
|
Health Risk |
Pathogenic |
Cognitive impairment and autistic features, X-linked recessive mitochondrial myopathy |
| RS1925492354 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS1925492808 |
CDKL5
|
Health Risk |
Likely pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS1925493252 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS192553687 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1925561449 |
PRPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth Neuropathy X, Charcot-Marie-Tooth Neuropathy X |
| RS1925573011 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS1925574557 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS1925577525 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS192561791 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, ADGRV1-related disorder |
| RS192567788 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1925696959 |
CDKL5
|
Health Risk |
Pathogenic/Likely pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS1925697105 |
CDKL5
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS1925697823 |
CDKL5
|
Health Risk |
Likely pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS1925701271 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS1925702601 |
CDKL5
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS192570479 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS1925705674 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS1925715512 |
PI4KA
|
Health Risk |
Pathogenic |
Spastic paraplegia 84, autosomal recessive |
| RS1925730100 |
PRPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth Neuropathy X, Nephrolithiasis/nephrocalcinosis |
| RS1925733148 |
PRPS1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1925845195 |
POU3F4
|
Health Risk |
Pathogenic |
— |
| RS1925845638 |
POU3F4
|
Health Risk |
Pathogenic |
— |
| RS192586920 |
PLCE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephrotic syndrome, type 3 |
| RS192587828 |
ANK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1925886368 |
AR
|
Health Risk |
Likely pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS1925886715 |
AR
|
Health Risk |
Pathogenic/Likely pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS192592067 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 4 |
| RS192592111 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Inborn genetic diseases |
| RS192594614 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS192602787 |
EYA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Branchiootic syndrome 1, Otofaciocervical syndrome 1 |
| RS192607073 |
GNPTAB
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS1926076502 |
TIMM8A
|
Health Risk |
Pathogenic |
Thyroid cancer, nonmedullary |
| RS1926076610 |
TIMM8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Deafness dystonia syndrome, Deafness dystonia syndrome |
| RS1926078505 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS1926080187 |
CDKL5
|
Health Risk |
Pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS1926080344 |
CDKL5
|
Health Risk |
Pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS192609440 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Melnick-Needles syndrome, Heterotopia |
| RS192610957 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS192618681 |
PDE6A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS192619553 |
CFAP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Heterotaxy, visceral |
| RS1926202120 |
CHM
|
Health Risk |
Pathogenic |
Choroideremia, Choroideremia |
| RS1926202704 |
CHM
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1926207659 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS1926208067 |
CHM
|
Health Risk |
Pathogenic |
Retinal dystrophy, CHM-related disorder |
| RS1926208868 |
CHM
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS192620988 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS1926219727 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1926220192 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia |
| RS192624334 |
TBCD
|
Health Risk |
Pathogenic |
— |
| RS1926253608 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS1926254082 |
CDKL5
|
Health Risk |
Pathogenic |
— |
| RS1926255341 |
CDKL5
|
Health Risk |
Pathogenic |
— |
| RS1926261579 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS1926262196 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS1926263167 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS1926264984 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1926267493 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS1926283743 |
CDKL5
|
Health Risk |
Pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS1926283887 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS192628905 |
CNGB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1926294168 |
CDKL5
|
Health Risk |
Conflicting classifications of pathogenicity |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS1926298368 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS1926298521 |
CDKL5
|
Health Risk |
Pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS192630178 |
TNNI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 2A, Hypertrophic cardiomyopathy 7 |
| RS1926301954 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS192630206 |
TMPRSS3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1926303951 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS1926305134 |
CDKL5
|
Health Risk |
Pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS1926352588 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1926354581 |
BTK
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1926358858 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, Thyroid cancer |
| RS1926378381 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1926380106 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS1926380816 |
BTK
|
Health Risk |
Pathogenic |
— |
| RS1926386296 |
PEX26
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 7A (Zellweger), Peroxisome biogenesis disorder 7B |
| RS192639023 |
MYO18B
|
Health Risk |
Conflicting classifications of pathogenicity |
MYO18B-related disorder, MYO18B-related disorder |
| RS192640017 |
EPHB4
|
Health Risk |
Conflicting classifications of pathogenicity |
Lymphatic malformation 7, Capillary malformation-arteriovenous malformation 2 |
| RS1926403854 |
PEX26
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 7A (Zellweger), Peroxisome biogenesis disorder 7B |
| RS1926404279 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1926404536 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, Thyroid cancer |
| RS192640536 |
ACTN1
|
Health Risk |
Likely pathogenic |
Abnormal bleeding, Thrombocytopenia |
| RS192644838 |
SIGMAR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive distal spinal muscular atrophy 2, Amyotrophic lateral sclerosis type 16 |
| RS1926450614 |
CDKL5
|
Health Risk |
Pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS1926471092 |
CDKL5
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS1926473501 |
CDKL5
|
Health Risk |
Pathogenic |
Seizure, Seizure |
| RS1926476615 |
CDKL5
|
Health Risk |
Likely pathogenic |
— |
| RS1926476996 |
BTK
|
Health Risk |
Pathogenic |
— |
| RS1926477495 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1926485817 |
PEX26
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 7A (Zellweger), Peroxisome biogenesis disorder 7A (Zellweger) |
| RS1926485824 |
NR0B1
|
Health Risk |
Likely pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS1926487809 |
PEX26
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 7A (Zellweger), Peroxisome biogenesis disorder 7B |
| RS192650285 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, Congenital muscular dystrophy due to partial LAMA2 deficiency |
| RS1926503277 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |